ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • Search
  • My Favorites
    • View and print all favorites
    • Clear all favorites

Abstract Number: 662

Can the New Contest Questionnaire Identify Psoriatic Arthritis in a Primary Care Population?

Laura C Coates, Laura J Savage, Anna R. Moverley and Philip S. Helliwell, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, United Kingdom

Meeting: ACR/ARHP Annual Meeting 2015

Date of first publication: September 29, 2015

Keywords: Education, patient, Primary care and psoriatic arthritis

  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print
Session Information

Date: Sunday, November 8, 2015

Title: Spondylarthropathies and Psoriatic Arthritis - Clinical Aspects and Treatment Poster I: Clinical Aspects and Assessments

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: There is a need for screening
questionnaires to identify patients with psoriasis who have undiagnosed
psoriatic arthritis but the optimal method is unknown.  We developed the
CONTEST questionnaires using the most discriminative items from 3 existing
tools: CONTEST consists of 8 yes/no items and CONTESTji the same items with the
addition of a joint manikin. Our aim was to test the new proposed CONTEST
questionnaires alongside the validated PEST questionnaire in a primary care
setting.

Methods: Patients with psoriasis were identified from
5 GP surgeries in Yorkshire and a random sample were invited to participate in
the study.  Patients had to be over 18 years old, have a diagnosis of psoriasis
and no diagnosis of PsA, RA or AS.  Consenting patients were asked to complete
the PEST and CONTEST questions and were then assessed by a dermatologist and
rheumatologist.  Diagnosis of PsA was made by the assessing rheumatologist as
lab and radiographic data were unavailable to assess the CASPAR criteria.  Receiver
operator characteristic (ROC) curve analysis was used to assess the PEST and
CONTEST questionnaires using physician diagnosis as the gold standard.
Sensitivity and specificity of potential cut points were examined.

Results: A total of 932 packs were sent out to
recruit 191 (20.5%) participants attending for assessment.  Of these, 169
(88.5%) had current or previous psoriasis.  Using physician diagnosis 17 (10.1%)
were found to have previously undiagnosed PsA, 90 (53.3%) were found to have
another musculoskeletal complaint and 62 (36.7%) had no musculoskeletal
problems. 

Using ROC curve analysis, all of the questionnaires showed a
significant ability to identify PsA.  The area under the curve (AUC) for the
CONTEST and CONTESTjt questionnaires was slightly higher than that of PEST (see
table 1) but there was no significant difference between any of the
questionnaires. Examining the sensitivities and specifities for the different
cut points, suggested that a PEST score of ≥2 would perform better in
this dataset, and optimal scores for CONTEST and CONTESTjt seemed to be 3 and 4
respectively.

Conclusion: The accuracy of the PEST and CONTEST
questionnaires to identify PsA appeared similar with slightly higher AUC for
the CONTEST questionnaires.  Optimal cut points in this study appeared lower
than in previous studies (PEST≥2, CONTEST≥3, CONTESTjt≥4).

 

Test

Score

AUC

Sensitivity

Specificity

PEST

2

0.652

0.824

0.449

 

3

0.652

0.529

0.660

 

4

0.652

0.235

0.816

CONTEST

2

0.694

0.882

0.388

 

3

0.694

0.765

0.565

 

4

0.694

0.529

0.680

 

5

0.694

0.353

0.816

CONTESTjt

2

0.704

0.941

0.337

 

3

0.704

0.765

0.531

 

4

0.704

0.706

0.633

 

5

0.704

0.412

0.735

 

6

0.704

0.353

0.844


Disclosure: L. C. Coates, Janssen Pharmaceutica Product, L.P., 2,Janssen Pharmaceutica Product, L.P., 8; L. J. Savage, Janssen Pharmaceutica Product, L.P., 8; A. R. Moverley, None; P. S. Helliwell, Janssen Pharmaceutica Product, L.P., 8,Pfizer Inc, 5.

To cite this abstract in AMA style:

Coates LC, Savage LJ, Moverley AR, Helliwell PS. Can the New Contest Questionnaire Identify Psoriatic Arthritis in a Primary Care Population? [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/can-the-new-contest-questionnaire-identify-psoriatic-arthritis-in-a-primary-care-population/. Accessed .
  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

« Back to ACR/ARHP Annual Meeting 2015

ACR Meeting Abstracts - https://acrabstracts.org/abstract/can-the-new-contest-questionnaire-identify-psoriatic-arthritis-in-a-primary-care-population/

Advanced Search

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology